Targovax Strengthens Management Team With the Appointment of Torbjørn Furuseth as CFO; Erik Digman Wiklund to become CBO |
| September 13, 2018 | September 2018 Bond Updates |
|
OSLO, Norway, Sept. 13, 2018 /PRNewswire/ -- Targovax ASA ("Targovax" or "the Company"; OSE: TRVX), a clinical stage biotechnology company developing immune activators to target hard to treat solid tumors, announces the appointment of Dr. Torbjørn Furuseth as CFO, effective 24 September... |
| View more at: https://www.prnewswire.com:443/news-releases/targovax-strengthens-management-team-with-the-appointment-of-torbjorn-furuseth-as-cfo-erik-digman-wiklund-to-become-cbo-300711907.html |
| Related News |
|